Revenue, 2025
USD 282.31 Mn
Forecast Year, 2035
USD 1,779.32 Mn
CAGR, 2025 - 2035
20.21%
Report Coverage
Worldwide
The global Generative AI in Life Sciences market, valued at USD 282.31B in 2025, is projected to surge to USD 1,779.32B by 2035, driven by AI-powered drug discovery, precision medicine, and advanced research, at a CAGR of 20.21%.
Generative AI In Life Sciences Market Size Analysis
Generative AI In Life Sciences Market Size By Technology 2025 to 2034 (USD Million)
| Technology | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Novel molecule generation | 18.78 | 22.66 | 27.22 | 32.71 | 39.48 | 47.73 | 57.46 | 68.66 | 82.50 | 99.63 |
| Protein sequence design | 37.81 | 45.18 | 54.42 | 65.61 | 78.68 | 94.84 | 113.55 | 136.96 | 164.34 | 197.57 |
| Synthetic gene design | 56.41 | 67.97 | 81.43 | 98.23 | 117.56 | 141.31 | 170.34 | 204.81 | 246.45 | 295.63 |
| Single-cell RNA sequencing | 75.42 | 90.51 | 108.92 | 130.80 | 157.30 | 189.00 | 226.99 | 272.26 | 327.82 | 394.77 |
| Data augmentation for model training | 93.89 | 113.05 | 135.96 | 163.04 | 196.49 | 235.77 | 283.52 | 341.33 | 409.87 | 492.16 |
Generative AI In Life Sciences Market Size By Application 2025 to 2034 (USD Million)
| Application | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Drug Discovery | 13.58 | 16.15 | 19.62 | 23.56 | 28.50 | 34.31 | 41.17 | 49.13 | 58.49 | 71.58 |
| Biotechnology | 26.82 | 32.40 | 39.01 | 47.01 | 56.15 | 67.41 | 81.04 | 97.35 | 116.93 | 140.77 |
| Medical Diagnosis | 40.34 | 48.60 | 58.36 | 69.98 | 84.20 | 101.62 | 121.85 | 146.73 | 176.53 | 211.88 |
| Clinical Trials | 53.76 | 64.67 | 77.66 | 93.54 | 112.12 | 134.66 | 162.01 | 195.22 | 234.46 | 281.69 |
| Precision and Personalized Medicine | 67.22 | 80.68 | 96.86 | 116.48 | 140.38 | 168.65 | 202.45 | 243.17 | 293.32 | 351.39 |
| Patient Monitoring | 80.58 | 96.86 | 116.44 | 139.84 | 168.15 | 201.99 | 243.35 | 292.43 | 351.24 | 422.46 |
Generative AI In Life Sciences Market Size By Region 2025 to 2034 (USD Million)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | 28.42 | 34.34 | 41.31 | 49.13 | 59.83 | 71.34 | 85.45 | 102.53 | 122.56 | 149.62 |
| LAMEA | 56.52 | 68.00 | 81.84 | 98.46 | 117.65 | 142.21 | 170.47 | 205.68 | 246.82 | 296.61 |
| Europe | 84.67 | 101.85 | 122.07 | 147.13 | 177.03 | 212.23 | 255.62 | 306.73 | 369.39 | 442.49 |
| Asia-Pacific | 112.70 | 135.17 | 162.72 | 195.68 | 234.99 | 282.87 | 340.32 | 409.10 | 492.22 | 591.03 |
Generative AI In Life Sciences Market Size to Hit USD 1779.32 Billion by 2035
The global generative ai in life sciences market size is evaluated at USD 282.31 billion in 2025 and is expected to grow around USD 1779.32 billion by 2035 with a registering a CAGR of 20.21%.
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com